New Findings from Codexis Inc. in the Area of Biological Tumor Markers Described (Enhancing the Imine Reductase Activity of a Promiscuous Glucose Dehydrogenase for Scalable Manufacturing of a Chiral Neprilysin Inhibitor Precursor)

Source :: Health & Medicine Week. May 24, 2024, 97
Publication Year :: 2024
Abstract: 2024 MAY 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Biological Factors - Biological Tumor Markers. According to [...]

Subjects :: Codexis Inc.
Research
Biocatalysts -- Research
Glucose -- Research
Tumor markers -- Research
Tumors -- Research
Biological products industry -- Research
Dextrose -- Research

Tools